Putting a Stop to Dysfunctional Uterine Bleeding
Download
Report
Transcript Putting a Stop to Dysfunctional Uterine Bleeding
Putting a Stop to Dysfunctional
Uterine Bleeding
By Denise McEnroe-Ayers, RN, MSN
and Mariann Montgomery, RN, MSN
Nursing2009, January 2009
2.3 ANCC/AACN contact hours
Online: www.nursingcenter.com
© 2008 by Lippincott Williams & Wilkins. All world rights reserved.
Abnormal uterine bleeding
Any uterine bleeding that differs in quantity,
duration, or frequency
Examples include:
- spotting between menstrual periods
- postmenopausal bleeding (occurs 12 months
or more after woman’s last menstrual period)
Dysfunctional uterine bleeding (DUB)
Relates to abnormal bleeding as a result of
hormonal changes directly affecting the
menstrual cycle in the absence of any identified
organic, systemic, or structural disease
May occur with or without ovulation
Normal menstrual cycle
Menstrual cycle is regulated by a complex
interaction of hypothalamus, anterior pituitary
gland, ovaries, and various target tissues (e.g.,
endometrium)
Normal menstrual function consists of two
distinct phases; estrogen and progesterone play
key roles
Normal menstrual cycle
Proliferative phase
Estrogen levels predominate
Ovarian follicles containing immature ova grow
and release estrogens that act on the uterus and
cause endometrium to become thick, vascular,
and proliferate
Corpus luteum develops from ovarian follicle
during midcycle; uses estrogens and
progesterone it produces to maintain its
structure
Normal menstrual cycle
Secretory phase
Begins when an increase in progesterone
triggers ovulation
If ovum isn’t fertilized, corpus luteum will atrophy
and estrogen and progesterone production
decline
Endometrium breaks down and menstruation
occurs
Menstruation: A complex event
When pregnancy doesn’t occur, sloughing of the
endometrial lining (menses) is expected result
Normal menstrual cycle occurs every 21 to 35
days and lasts 2 to 7 days
On average, women lose 30 to 80 mLs of fluid,
most occurring in first 3 days
Understanding DUB
When normal menstrual cycle is disrupted,
usually due to anovulation (failure to ovulate)
Women whose cycle vary in length by more than
10 days are usually anovulatory
Women under 20 and over 40 are at risk due to
hormonal imbalances and anovulation at
beginning and end of reproductive lives
Signs and symptoms
Menorrhagia - blood flow more than 80 mLs or
lasting more than 7 days
Polymenorrhagia - menstrual cycle less than 21
days
Oligomenorrhea – menstrual cycle lasting longer
than 35 days
Signs and symptoms
Metrorrhagia - bleeding at irregular but frequent
intervals
Menometrorrhagia - prolonged or excessive
bleeding at irregular or unpredictable intervals
Causes of abnormal bleeding
Most common cause in women of child-bearing
age is pregnancy (and pregnancy-related
conditions, e.g., miscarriage)
Other causes:
- Infection of genital tract
- Uterine fibroids
- Endometrial cancer
Causes of abnormal bleeding
- Certain medications (anticoagulants,
corticosteroids)
- Herbals (ginkgo)
- Blood dyscrasias
- Thyroid or adrenal disorders
- Liver or kidney disease
- Stress
Categories of DUB
Anovulatory (90% of cases)
Common in women at beginning/end of
reproductive life
Estrogen secreted, but ovum doesn’t ripen
Progesterone not produced to counteract
uterine lining proliferation
Anovulatory DUB
Patient has irregular, possibly heavy bleeding
In absence of ovulation will not experience
typical signs: cramping, mood changes, breast
tenderness
Unopposed estrogen has been linked to
endometrial hyperplasia and cancer
Categories of DUB
Ovulatory
More likely to occur during peak reproductive
years
Associated with prolonged progesterone
secretion or prostaglandin release
Leads to heavy but predictable bleeding
Ovulatory DUB
May also coexist with tumors or polyps that
contribute to excessive bleeding
Women with ovulatory DUB experience
premenstrual and menstrual signs and
symptoms
Symptoms linked to ovulation and progesterone
Risk factors
Age under 20 or over 40
Overweight/extreme weight loss or gain
Excessive exercise
High stress levels
Polycystic ovarian syndrome
Diagnosis
Obtain detailed gynecologic/obstetric history
Medication history
Physical assessment to include vital signs,
height and weight, thyroid gland
Past medical history
Tracking signs and symptoms
Use of menstruation calendar or menstrual flow
diary can help patient compare how her current
menstrual cycle differs from her normal cycles in
duration, frequency, and intensity. Teach her to
record:
Daily temperatures, taken each morning before
she gets out of bed; an elevation in body
temperature can indicate ovulation
When her periods start and stop
Tracking signs and symptoms
Amount of bleeding (number of saturated pads
or tampons)
Contraceptive use and sexual activity
Any problems such as pain, clots, postcoital
bleeding, or bleeding that requires more than
one pad or tampon every hour
If menstruation causes social embarrassment or
inconvenience, compromises sexual activity, or
requires her to change her lifestyle
Delving deeper
Pelvic examination. American College of
Obstetricians recommends endometrial
evaluation/biopsy for all women over 35 and at
high risk of cancer
Lab work. Should include pregnancy test/CBC
Imaging studies. May nclude pelvic ultrasound
to rule out tumors, cysts, polyps
Treatment
Mainstay for DUB is combination oral
contraceptive therapy containing estrogen and
progesterone or cyclical progesterone
Generally prescribed for at least 3 months
before other options are considered
Common treatment regimens
Mild bleeding - contraceptive started with next
menstrual cycle
Moderate to heavy bleeding - patient may take
progestin for 10 to 21 days followed by normal
contraceptive regimen with next menstrual cycle
Intrauterine device containing progesterone
Common treatment regimens
Depo-Provera may be used (contraindicated in
undiagnosed vaginal bleeding)
Gonadotropin releasing hormone - leuprolide
(Lupron)
Treating ovulatory DUB
Continuous estrogen secretion unopposed by
progesterone causes buildup of endometrium
and prostaglandin imbalance
NSAIDs decrease prostaglandin production,
reduce blood flow, ease cramping
NSAIDs are contraindicated in bleeding and
platelet disorders
NSAID therapy
Teach patient to take drug 1 to 2 days before
she expects her period
Continue taking it throughout her menses as
prescribed
Beyond medication
Hysteroscopy. Allows for visualization if
bleeding persists, removal of polyps if found
Uterine artery embolization. Causes loss of
blood flow to fibroids, causing them to shrink
Dilation and curettage. Controls acute bleeding
that doesn’t respond to medication
Beyond medication
Endometrial ablation. Uses microwave
radiofrequency to destroy uterine lining, done in
patient who doesn’t want children (renders
patient infertile)
Hysterectomy. Last resort in DUB related to
other causes such as cancer
Patient teaching and support
Call healthcare provider if you pass clots, soak a
pad every hour, or develop severe abdominal
pain
Take medications as prescribed
Take NSAIDs for pain (avoid aspirin)
Get plenty of iron in your diet
Patient teaching and support
Rest frequently to manage fatigue
Contact healthcare provider right away if you
experience dizziness or heart palpitations
May engage in activities of daily living:
swimming, sexual intercourse, exercise